Effect of short term administration of cinnamon on blood pressure in patients with pre and type 2 diabetes

Nutrition (Impact Factor: 2.93). 05/2013;

ABSTRACT Objective:
To systematically review and evaluate the effect of short term administration of cinnamon on blood pressure regulation in pre and type 2 diabetes patients by performing a meta-analysis of randomized placebo-controlled clinical trials.

Research Methods and Procedures:
Medical literature for randomized controlled trials (RCTs) of the effect of cinnamon on blood pressure was systematically searched; 3 original articles published from January 2000 to September 2012 were identified from the MEDLINE database and a hand search of the reference lists of the articles obtained through MEDLINE. The search terms included cinnamon or blood pressure or systolic blood pressure (SBP) or diastolic blood pressure (DBP) or diabetes. A random effects model was used to calculate weighted mean difference and 95% confidence intervals (CI).

The pooled estimate of the effect of cinnamon intake on systolic and diastolic blood pressure demonstrated that the use of cinnamon significantly decreased SBP and DBP by 5.39 mmHg (95% CI: -6.89, -3.89) and 2.6 mmHg (95% CI: - 4.53, -0.66) respectively.

Consumption of cinnamon (short term) is associated with notable reduction of SBP and DBP. Although cinnamon shows hopeful effects on blood pressure lowering potential, it would be premature to recommend cinnamon for blood pressure control, because of the limited number of studies available. Thus, undoubtedly a long term, adequately powered RCTs involving a larger number of patients is needed to appraise the clinical potential of cinnamon on blood pressure control among patients with type 2 diabetes mellitus.

Key words: Blood pressure, Diabetes, Cinnamon, Blood glucose, randomized control trials.

Download full-text


Available from: Amalia Tsiami, Sep 28, 2015
78 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Naturally-occurring compounds that have been shown to improve insulin sensitivity include Cr and polyphenols found in cinnamon (Cinnamomon cassia). These compounds also have similar effects on insulin signalling and glucose control. The signs of Cr deficiency are similar to those for the metabolic syndrome and supplemental Cr has been shown to improve all these signs in human subjects. In a double-blind placebo-controlled study it has been demonstrated that glucose, insulin, cholesterol and HbA1c are all improved in patients with type 2 diabetes following Cr supplementation. It has also been shown that cinnamon polyphenols improve insulin sensitivity in in vitro, animal and human studies. Cinnamon reduces mean fasting serum glucose (18-29%), TAG (23-30%), total cholesterol (12-26%) and LDL-cholesterol (7-27%) in subjects with type 2 diabetes after 40 d of daily consumption of 1-6 g cinnamon. Subjects with the metabolic syndrome who consume an aqueous extract of cinnamon have been shown to have improved fasting blood glucose, systolic blood pressure, percentage body fat and increased lean body mass compared with the placebo group. Studies utilizing an aqueous extract of cinnamon, high in type A polyphenols, have also demonstrated improvements in fasting glucose, glucose tolerance and insulin sensitivity in women with insulin resistance associated with the polycystic ovary syndrome. For both supplemental Cr and cinnamon not all studies have reported beneficial effects and the responses are related to the duration of the study, form of Cr or cinnamon used and the extent of obesity and glucose intolerance of the subjects.
    Proceedings of The Nutrition Society 03/2008; 67(1):48-53. DOI:10.1017/S0029665108006010 · 5.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine the prevalence of CVD and renal disease by glucose tolerance status in a population-based study. The study consisted of 991 men and 1243 women, aged 50-89 yr, living in the upper-middle class community of Rancho Bernardo, CA. All participants received a standard OGTT between 1984 and 1987. A total of 159 men and 158 women had NIDDM, whereas 237 men and 348 women had IGT. Age-adjusted prevalence of complications generally was highest in those who were previously diagnosed with NIDDM. A significant correlation was observed between increases in the prevalence of complications and increases in glucose intolerance for microproteinuria, macroproteinuria, and myocardial infarction (borderline), as well as for stroke and claudication in men and myocardial infarction and stroke in women. In men with IGT or NIDDM, the age-adjusted prevalence of proteinuria and CVD was highest when other complications were present whereas in women such a prevalence was highest when other complications were absent. In men with diabetes, microproteinuria was associated with duration of disease. Prevalent CVD and renal disease were increased in adults with NIDDM and elevated in adults with IGT compared to those with normal glucose tolerance. The prevalence of complications in NIDDM subjects in this population-based study was substantially lower than that reported for clinic-based diabetic populations.
    Diabetes Care 08/1993; 16(7):1022-5. DOI:10.2337/diacare.16.7.1022 · 8.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypertension in patients with type 2 diabetes mellitus is a prevalent condition that leads to substantial morbidity and mortality. To evaluate the goals and optimal agents for treatment of hypertension in type 2 diabetes. Review of the medical literature Randomized trials that evaluated the pharmacologic treatment of hypertension in patients with diabetes and reported microvascular and macrovascular outcomes. Studies were identified by using the Cochrane Library, MEDLINE, meta-analyses, review articles, and expert recommendation. The searches of the Cochrane Library and MEDLINE were performed in May 2000 and updated in April 2002. Data were abstracted to standardized forms by a single reviewer and were confirmed by a second reviewer. Treatment of hypertension in type 2 diabetes provides dramatic benefit. Target diastolic blood pressures of less than 80 mm Hg appear optimal; systolic targets have not been as rigorously evaluated, but targets of 135 mm Hg or less are reasonable. Studies that compare drug classes do not suggest obviously superior agents. However, it is reasonable to conclude that thiazide diuretics, angiotensin-II receptor blockers, and perhaps angiotensin-converting enzyme (ACE) inhibitors may be the preferred first-line agents for treatment of hypertension in diabetes. beta-Blockers and calcium-channel blockers are more effective than placebo, but they may not be as effective as diuretics, angiotensin-II receptor blockers, or ACE inhibitors; however, study results are inconsistent in this regard. Treatment of hypertension in type 2 diabetes, with blood pressure goals of 135/80 mm Hg, provides dramatic benefits. Thiazide diuretics, angiotensin II receptor blockers, and ACE inhibitors may be the best first-line treatments, although other agents are usually necessary and goals may not be achieved even with three or four agents. Aggressive blood pressure control may be the most important factor in preventing adverse outcomes in patients with type 2 diabetes.
    Annals of internal medicine 05/2003; 138(7):593-602. DOI:10.7326/0003-4819-138-7-200304010-00018 · 17.81 Impact Factor
Show more